Statin Intolerant Patient:Development of Patient Reported Questionaire

• Research type

  Research Study

• Full title

  Understanding the Experience of the Statin Intolerant Patient: Development and Preliminary Evaluation of a Patient-Reported Questionnaire

• IRAS ID

  226358

• Contact name

  Jaimini Cegla

• Contact email

  j.cegla@imperial.ac.uk

• Sponsor organisation

  Amgen Inc

• Clinicaltrials.gov Identifier

  #20160434, Amgen Protocol

• Duration of Study in the UK

  2 years, 2 months, 1 days

• Research summary

  The overall aim of the study is to develop and test a patient-reported survey instrument to assess experiences with symptoms of statin intolerance.
  This development process will include both qualitative research activities to support initial instrument construction and a quantitative pilot study to further evaluate the newly-developed questionnaire.

• REC name

  East of England - Cambridgeshire and Hertfordshire Research Ethics Committee

• REC reference

  17/EE/0164

• Date of REC Opinion

  26 May 2017

• REC opinion

  Further Information Favourable Opinion